AllerGene AI Therapeutics

About

AllerGene AI Therapeutics is pioneering the first in vivo mRNA-LNP CAR-T platform designed to eliminate disease-driving mast cells, safely resetting the immune system without permanent alteration. Mast cells are central drivers of mast-cell-driven diseases such as mastocytosis and chronic urticaria and are the cellular source of the mediators that cause allergic and anaphylactic reactions.

Product

Value proposition

Using in vivo–delivered mRNA CAR-T cells to precisely eliminate mast cells—the root cause of severe allergic reactions—safely resetting the immune system without permanent alteration.

Founders

• Sid Kerkar, M.D. — CEO & Founder

Categories

Products

Key features

Technologies

Target conditions

Investors

News

• AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors · 2026-06-09T12:30:00.000Z
• AllerGene AI Therapeutics Adds Biotech Executive Gad Berdugo to Board Following Investment | citybiz · 2026-06-09T15:07:58.000Z
• AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad ...
• Sid P. Kerkar's Post - LinkedIn
• AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors - Worldnews.com · 2026-06-09T00:00:00.000Z
• AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors | lifestyle.rogueimc.org · 2026-06-09T12:48:22.000Z

Browse similar startups

Related startups

• altRX — Tampa, FL
• BC Medical Billing LLC — Hollywood, FL
• Bea Better Eating — St. Petersburg, FL
• Benefitly — Pensacola, FL
• BOCA RATON SKIN INSTITUTE — Boca Raton, FL
• BREVARD VISION CENTER INC — Rockledge, FL
• Alliance Family Medicine — Flower Mound, TX
• AllRx — Alhambra, CA
• allumbra — Broomfield, CO
• Alpine Dermatology Assoc — Lakewood, CO
• Alta Smiles — Fort Washington, WA
• Althea Health — San Jose, CA